סימברינזה

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

BRIMONIDINE TARTRATE; BRINZOLAMIDE

متاح من:

NOVARTIS ISRAEL LTD

ATC رمز:

S01EC54

تركيب:

BRIMONIDINE TARTRATE 2 MG/ML; BRINZOLAMIDE 10 MG/ML

طريقة التعاطي:

עיני

نوع الوصفة الطبية :

מרשם נדרש

المصنعة من قبل:

ALCON COUVREUR N.V., BELGIUM

المجال العلاجي:

BRINZOLAMIDE, COMBINATIONS

تاريخ الترخيص:

2022-05-31

نشرة المعلومات

PATIENT PACKAGE INSERT IN ACCORDANC
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s
prescription only
SIMBRINZA
®
EYE DROPS, SUSPENSION
ACTIVE INGREDIENTS:
Brimonidine tartrate 2 mg/ml
Brinzolamide 10 mg/ml
Inactive and allergenic ingredients in the
preparation appear in section 6 “Further
Information” and in section 2 “Important information
about some of the ingredients of the medicine”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE
USING THE MEDICINE. This leaflet contains concise
information about the medicine. If you have further
questions, refer to the doctor or pharmacist. This
medicine has been prescribed for the treatment
of your ailment. Do not pass it on to others. It may
harm them, even if it seems to you that their medical
condition is similar.
The medicine is intended for use by adults over
the age of 18.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended for the reduction of
intraocular pressure in adults (over 18 years
of age) in cases of glaucoma or intraocular
hypertension in patients who do not fully respond
to treatment for intraocular pressure with a single
medicine.
THERAPEUTIC GROUP:
Brimonidine tartrate – alpha-2 adrenergic receptor
agonist.
Brinzolamide – carbonic anhydrase inhibitor.
Both ingredients work together to reduce
intraocular pressure.
2.
BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
• You have a known sensitivity (allergy) to
brinzolamide or brimonidine tartrate or to any
of the other ingredients of the medicine (see
section 6 “Further Information”).
• You are sensitive (allergic) to medicines from
the sulphonamide group (such as: medicines
for the treatment of diabetes, for the treatment
of infections and diuretics).
• You are taking medicines that inhibit the enzyme
monoamine oxidase (such as medicines for the
treatment of depression or Parkinson’s disease)
or certain anti-depressants. You must inform the
doctor if you are taking any anti-depressants.
• You suffer from s